Current research for a vaccine against Lassa hemorrhagic fever virus

References

• RobertsLNigeria hit by unprecedented Lassa fever outbreakScience201835963811201120229590055
   PubMed Web of Science ®Google Scholar
• FrameJDBaldwinJMJrGockeDJTroupJMLassa fever, a new virus disease of man from West Africa. I. Clinical description and pathological findingsAm J Trop Med Hyg19701946706764246571
   PubMed Web of Science ®Google Scholar
• MonathTPNewhouseVFKempGESetzerHWCacciapuotiALassa virus isolation from Mastomys natalensis rodents during an epidemic in Sierra LeoneScience197418541472632654833828
   PubMed Web of Science ®Google Scholar
• SchlieKMaisaALennartzFStröherUGartenWStreckerTCharacterization of Lassa virus glycoprotein oligomerization and influence of cholesterol on virus replicationJ Virol201084298399219889753
   PubMed Web of Science ®Google Scholar
• McCormickJBKingIJWebbPAA case-control study of the clinical diagnosis and course of Lassa feverJ Infect Dis198715534454553805772
   PubMed Web of Science ®Google Scholar
• BauschDGHadiCMKhanSHLertoraJJReview of the literature and proposed guidelines for the use of oral ribavirin as postexposure prophylaxis for Lassa feverClin Infect Dis201051121435144121058912
   PubMed Web of Science ®Google Scholar
• MacherAMWolfeMSHistorical Lassa fever reports and 30-year clinical updateEmerg Infect Dis200612583583716704848
   PubMed Web of Science ®Google Scholar
• McCormickJBEpidemiology and control of Lassa feverCurr Top Microbiol Immunol198713469783581899
   PubMed Web of Science ®Google Scholar
• BaizeSKaplonJFaureCPannetierDGeorges-CourbotMCDeubelVLassa virus infection of human dendritic cells and macrophages is productive but fails to activate cellsJ Immunol200417252861286914978087
   PubMed Web of Science ®Google Scholar
• BaizeSPannetierDFaureCRole of interferons in the control of Lassa virus replication in human dendritic cells and macrophagesMicrobes Infect2006851194120216621649
   PubMed Web of Science ®Google Scholar
• PannetierDFaureCGeorges-CourbotMCDeubelVBaizeSHuman macrophages, but not dendritic cells, are activated and produce alpha/beta interferons in response to Mopeia virus infectionJ Virol20047819105161052415367618
   PubMed Web of Science ®Google Scholar
• JahrlingPBHesseRAEddyGAJohnsonKMCallisRTStephenELLassa virus infection of rhesus monkeys: pathogenesis and treatment with ribavirinJ Infect Dis198014155805896768812
   PubMed Web of Science ®Google Scholar
• BaizeSMarianneauPLothPEarly and strong immune responses are associated with control of viral replication and recovery in lassa virus-infected cynomolgus monkeysJ Virol200983115890590319297492
   PubMed Web of Science ®Google Scholar
• YunNEPoussardALSereginAVFunctional interferon system is required for clearance of lassa virusJ Virol20128663389339222238311
   PubMed Web of Science ®Google Scholar
• OestereichLLüdtkeARuibalPChimeric mice with competent hematopoietic immunity reproduce key features of severe lassa feverPLoS Pathog2016125e100565627191716
   PubMed Web of Science ®Google Scholar
• YunNESereginAVWalkerDHMice lacking functional STAT1 are highly susceptible to lethal infection with Lassa virusJ Virol20138719109081091123903830
   PubMed Web of Science ®Google Scholar
• XingJLyHLiangYThe Z proteins of pathogenic but not nonpathogenic arenaviruses inhibit RIG-I-like receptor-dependent interferon productionJ Virol20158952944295525552708
   PubMed Web of Science ®Google Scholar
• PythoudCRodrigoWWPasqualGArenavirus nucleoprotein targets interferon regulatory factor-activating kinase IKKεJ Virol201286157728773822532683
   PubMed Web of Science ®Google Scholar
• RodrigoWWOrtiz-RiañoEPythoudCKunzSde la TorreJCMartínez-SobridoLArenavirus nucleoproteins prevent activation of nuclear factor kappa BJ Virol201286158185819722623788
   PubMed Web of Science ®Google Scholar
• HastieKMKingLBZandonattiMASaphireEOStructural basis for the dsRNA specificity of the Lassa virus NP exonucleasePLoS One201278e4421122937163
   PubMed Web of Science ®Google Scholar
• JiangXHuangQWangWStructures of arenaviral nucleoproteins with triphosphate dsRNA reveal a unique mechanism of immune suppressionJ Biol Chem201328823169491695923615902
   PubMed Web of Science ®Google Scholar
• PrescottJBMarziASafronetzDRobertsonSJFeldmannHBestSMImmunobiology of Ebola and Lassa virus infectionsNat Rev Immunol201717319520728111475
   PubMed Web of Science ®Google Scholar
• RussierMPannetierDBaizeSImmune responses and Lassa virus infectionViruses20124112766278523202504
   PubMed Web of Science ®Google Scholar
• CarrionRJrBraskyKMansfieldKLassa virus infection in experimentally infected marmosets: liver pathology and immunophenotypic alterations in target tissuesJ Virol200781126482649017409137
   PubMed Web of Science ®Google Scholar
• MeulenJtBaduscheMSatoguinaJOld and New World arenaviruses share a highly conserved epitope in the fusion domain of the glycoprotein 2, which is recognized by Lassa virus-specific human CD4+ T-cell clonesVirology2004321113414315033572
   PubMed Web of Science ®Google Scholar
• ter MeulenJBaduscheMKuhntKCharacterization of human CD4(+) T-cell clones recognizing conserved and variable epitopes of the Lassa virus nucleoproteinJ Virol20007452186219210666248
   PubMed Web of Science ®Google Scholar
• PannetierDReynardSRussierMHuman dendritic cells infected with the nonpathogenic Mopeia virus induce stronger T-cell responses than those infected with Lassa virusJ Virol201185168293830621632749
   PubMed Web of Science ®Google Scholar
• GeisbertTWJonesSFritzEADevelopment of a new vaccine for the prevention of Lassa feverPLoS Med200526e18315971954
   PubMed Web of Science ®Google Scholar
• FlatzLRiegerTMerklerDT cell-dependence of Lassa fever pathogenesisPLoS Pathog201063e100083620360949
   PubMed Web of Science ®Google Scholar
• GüntherSKühleORehderDAntibodies to Lassa virus Z protein and nucleoprotein co-occur in human sera from Lassa fever endemic regionsMed Microbiol Immunol2001189422522911599793
   PubMed Web of Science ®Google Scholar
• Fisher-HochSPHutwagnerLBrownBMcCormickJBEffective vaccine for lassa feverJ Virol200074156777678310888616
   PubMed Web of Science ®Google Scholar
• LukashevichISPushkoPVaccine platforms to control Lassa feverExpert Rev Vaccines20161591135115027136941
   PubMed Web of Science ®Google Scholar
• Fisher-HochSPMcCormickJBLassa fever vaccineExpert Rev Vaccines20043218919715056044
   PubMedGoogle Scholar
• FrameJDVerbruggeGPGillRGPinneoLThe use of Lassa fever convalescent plasma in NigeriaTrans R Soc Trop Med Hyg19847833193246464130
   PubMed Web of Science ®Google Scholar
• JahrlingPBPetersCJPassive antibody therapy of Lassa fever in cynomolgus monkeys: importance of neutralizing antibody and Lassa virus strainInfect Immun19844425285336715049
   PubMed Web of Science ®Google Scholar
• JahrlingPBPetersCJStephenELEnhanced treatment of Lassa fever by immune plasma combined with ribavirin in cynomolgus monkeysJ Infect Dis198414934204276715898
   PubMed Web of Science ®Google Scholar
• CrossRWMireCEBrancoLMTreatment of Lassa virus infection in outbred guinea pigs with first-in-class human monoclonal antibodiesAntiviral Res201613321822227531367
   PubMed Web of Science ®Google Scholar
• MireCECrossRWGeisbertJBHuman-monoclonal-antibody therapy protects nonhuman primates against advanced Lassa feverNat Med201723101146114928869611
   PubMed Web of Science ®Google Scholar
• PushkoPGeisbertJParkerMJahrlingPSmithJIndividual and bivalent vaccines based on alphavirus replicons protect guinea pigs against infection with Lassa and Ebola virusesJ Virol20017523116771168511689649
   PubMed Web of Science ®Google Scholar
• WangMJokinenJTretyakovaIPushkoPLukashevichISAlphavirus vector-based replicon particles expressing multivalent cross-protective Lassa virus glycoproteinsVaccine201836568369029287681
   PubMed Web of Science ®Google Scholar
• McCormickJBMitchellSWKileyMPRuoSFisher-HochSPInactivated Lassa virus elicits a non protective immune response in rhesus monkeysJ Med Virol1992371171619397
   PubMed Web of Science ®Google Scholar
• CashmanKABroderickKEWilkinsonEREnhanced efficacy of a codon-optimized DNA vaccine encoding the glycoprotein precursor gene of Lassa virus in a guinea pig disease model when delivered by dermal electroporationVaccines (Basel)20131326227726344112
   PubMedGoogle Scholar
• CashmanKAWilkinsonERShaiaCIA DNA vaccine delivered by dermal electroporation fully protects cynomolgus macaques against Lassa feverHum Vaccin Immunother201713122902291129045192
   PubMed Web of Science ®Google Scholar
• CashmanKAWilkinsonERWollenSEDNA vaccines elicit durable protective immunity against individual or simultaneous infections with Lassa and Ebola viruses in guinea pigsHum Vaccin Immunother201713123010301929135337
   PubMed Web of Science ®Google Scholar
• SafronetzDRosenkeKWestoverJBThe broad-spectrum antiviral favipiravir protects guinea pigs from lethal Lassa virus infection post-disease onsetSci Rep201551477526456301
   PubMed Web of Science ®Google Scholar
• CleggJCLloydGVaccinia recombinant expressing Lassa-virus internal nucleocapsid protein protects guinea pigs against Lassa feverLancet1987285521861882885642
   PubMed Web of Science ®Google Scholar
• MorrisonHGBauerSPLangeJVEspositoJJMcCormickJBAuperinDDProtection of guinea pigs from Lassa fever by vaccinia virus recombinants expressing the nucleoprotein or the envelope glycoproteins of Lassa virusVirology198917111791882741340
   PubMed Web of Science ®Google Scholar
• LukashevichISVasiuchkovADStel’makhTAScheslenokEPShabanovAGThe isolation and characteristics of reassortants between the Lassa and Mopeia arenavirusesVopr Virusol1991362146150 Russian [with English abstract]1882522
   PubMed Web of Science ®Google Scholar
• LukashevichISGeneration of reassortants between African arenavirusesVirology199218826006051585636
   PubMed Web of Science ®Google Scholar
• MoshkoffDASalvatoMSLukashevichISMolecular characterization of a reassortant virus derived from Lassa and Mopeia virusesVirus Genes200734216917617143722
   PubMed Web of Science ®Google Scholar
• CarrionRJrPattersonJLJohnsonCA ML29 reassortant virus protects guinea pigs against a distantly related Nigerian strain of Lassa virus and can provide sterilizing immunityVaccine200725204093410217360080
   PubMed Web of Science ®Google Scholar
• LukashevichISCarrionRJrSalvatoMSSafety, immunogenicity, and efficacy of the ML29 reassortant vaccine for Lassa fever in small non-human primatesVaccine200826415246525418692539
   PubMed Web of Science ®Google Scholar
• BredenbeekPJMolenkampRSpaanWJA recombinant Yellow Fever 17D vaccine expressing Lassa virus glycoproteinsVirology2006345229930416412488
   PubMed Web of Science ®Google Scholar
• JiangXDaleboutTJBredenbeekPJYellow fever 17D-vectored vaccines expressing Lassa virus GP1 and GP2 glycoproteins provide protection against fatal disease in guinea pigsVaccine20112961248125721145373
   PubMed Web of Science ®Google Scholar
• LukashevichISAdvanced vaccine candidates for Lassa feverViruses20124112514255723202493
   PubMed Web of Science ®Google Scholar
• Henao-RestrepoAMLonginiIMEggerMEfficacy and effectiveness of an rVSV-vectored vaccine expressing Ebola surface glycoprotein: interim results from the Guinea ring vaccination cluster-randomised trialLancet2015386999685786626248676
   PubMed Web of Science ®Google Scholar
• MarziAEngelmannFFeldmannFAntibodies are necessary for rVSV/ZEBOV-GP-mediated protection against lethal Ebola virus challenge in nonhuman primatesProc Natl Acad Sci U S A201311051893189823319647
   PubMed Web of Science ®Google Scholar
• MireCEGeisbertJBAgansKNDurability of a vesicular stomatitis virus-based marburg virus vaccine in nonhuman primatesPLoS One201494e9435524759889
   PubMed Web of Science ®Google Scholar
• GarbuttMLiebscherRWahl-JensenVProperties of replication-competent vesicular stomatitis virus vectors expressing glycoproteins of filoviruses and arenavirusesJ Virol200478105458546515113924
   PubMed Web of Science ®Google Scholar
• SafronetzDStrongJEFeldmannFA recently isolated Lassa virus from Mali demonstrates atypical clinical disease manifestations and decreased virulence in cynomolgus macaquesJ Infect Dis201320781316132723303805
   PubMed Web of Science ®Google Scholar
• SafronetzDMireCRosenkeKA recombinant vesicular stomatitis virus-based Lassa fever vaccine protects guinea pigs and macaques against challenge with geographically and genetically distinct Lassa virusesPLoS Negl Trop Dis201594e000373625884628
   PubMed Web of Science ®Google Scholar
• MarziAFeldmannFGeisbertTWFeldmannHSafronetzDVesicular stomatitis virus-based vaccines against Lassa and Ebola virusesEmerg Infect Dis201521230530725625358
   PubMed Web of Science ®Google Scholar
• AuperinDDEspositoJJLangeJVConstruction of a recombinant vaccinia virus expressing the Lassa virus glycoprotein gene and protection of guinea pigs from a lethal Lassa virus infectionVirus Res198892–32332483354260
   PubMed Web of Science ®Google Scholar
• Fisher-HochSPMcCormickJBAuperinDProtection of rhesus monkeys from fatal Lassa fever by vaccination with a recombinant vaccinia virus containing the Lassa virus glycoprotein geneProc Natl Acad Sci U S A19898613173212911575
   PubMed Web of Science ®Google Scholar
• LukashevichISPattersonJCarrionRA live attenuated vaccine for Lassa fever made by reassortment of Lassa and Mopeia virusesJ Virol20057922139341394216254329
   PubMed Web of Science ®Google Scholar
• World Health Organization2018World Health Organization Lassa Fever Nigeria Report Available from: http://www.who.int/csr/don/23-march-2018-lassa-fever-nigeria/en/Accessed April 07, 2018
   Google Scholar